FierceBiotech 2026-01-29 Sanofi keeps mum on future of disappointing Denali pact after scrapping final RIPK1 inhibitor
FierceBiotech 2026-01-29 AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities
FierceBiotech 2026-01-29 Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B
FierceBiotech 2026-01-28 Reducing animal testing 'an evolution and not a revolution' for life sci R&D, Charles River's incoming CEO says
FierceBiotech 2026-01-28 New compound shrinks brain tumors in mice, sparking hope for a glioblastoma pill
FierceBiotech 2026-01-28 Halozyme catches M&A wave to snap up Surf Bio in delivery tech deal worth up to $400M
FierceBiotech 2026-01-28 Lilly pens $1.1B pact with German biotech to work on gene editing med for hearing loss
FierceBiotech 2026-01-28 Medtech M&A 'rebounded' in 2025 as softer valuations drove deal competition: report
FierceBiotech 2026-01-28 CalciMedica stock craters as calcium channel inhibitor trial stopped over 'safety concern'
FierceBiotech 2026-01-28 FDA puts clinical hold on Regenxbio gene therapies weeks before approval ruling
FierceBiotech 2026-01-28 'We have an expansive view:' Kardigan CEO knits sharper trials, digital health into cardio strategy
FierceBiotech 2026-01-27 Rethinking heart attacks as nervous system gone haywire sparks potential new drug targets
FierceBiotech 2026-01-27 TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio
FierceBiotech 2026-01-27 'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership
FierceBiotech 2026-01-27 United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial
FierceBiotech 2026-01-27 From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot